Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
The OncLive Insider app is live!
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
The OncLive Insider app is live!
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Precision Medicine: A New Frontier for Advanced Cholangiocarcinoma
EP. 1: Diagnosing CCA
October 21st 2019
EP. 2: Heterogeneity of CCA
October 21st 2019
EP. 3: Tumor Markers in CCA
October 21st 2019
EP. 4: Prevalence of CCA
October 21st 2019
EP. 5: Adjuvant Chemotherapy for CCA
October 21st 2019
EP. 6: Radiation Therapy for CCA
October 21st 2019
EP. 7: Frontline Therapy for CCA
October 21st 2019
EP. 8: Second-Line Therapy for CCA
October 21st 2019
EP. 9: Molecular Testing for CCA
October 21st 2019
EP. 10: Mutual Exclusivity in CCA
October 21st 2019
EP. 11: Infigratinib for CCA
October 21st 2019
EP. 12: FGFR Inhibitors in Development for CCA
October 21st 2019
EP. 13: Ivosidenib for Advanced IDH1-Mutated CCA
October 21st 2019
EP. 14: ClarIDHy Phase III Trial of Ivosidenib in CCA
October 21st 2019
EP. 15: Final Thoughts on CCA
October 21st 2019
x
